<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2917494</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:570</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Kristian</namePart>
  <namePart type="family">Müller</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">37324073</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0002-7914-0625</description></name>
<name type="personal">
  <namePart type="given">Georg</namePart>
  <namePart type="family">Falck</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">61822521</identifier></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">37803853</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Strategies for site-specific modification of proteins have increased in number, complexity, and specificity over the last years. Such modifications hold the promise to broaden the use of existing biopharmaceuticals or to tailor novel proteins for therapeutic or diagnostic applications. The recent quest for next-generation antibody–drug conjugates (ADCs) sparked research into techniques with site selectivity. While purely chemical approaches often impede control of dosage or locus of derivatization, naturally occurring enzymes and proteins bear the ability of co- or post-translational protein modifications at particular residues, thus enabling unique coupling reactions or protein fusions. This review provides a general overview and focuses on chemo-enzymatic methods including enzymes such as formylglycine-generating enzyme, sortase, and transglutaminase. Applications for the conjugation of antibodies and antibody mimetics are reported. View Full-Text</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="antibodies-07-00004.mueller.pdf">https://pub.uni-bielefeld.de/download/2917494/2917496/antibodies-07-00004.mueller.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>MDPI AG</publisher><dateIssued encoding="w3cdtf">2018</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>

<subject><topic>chemo-enzymatic labeling</topic><topic>armed antibody</topic><topic>antibody coupling</topic><topic>antibody conjugation</topic>
</subject>


<relatedItem type="host"><titleInfo><title>Antibodies</title></titleInfo>
  <identifier type="issn">2073-4468</identifier>
  <identifier type="MEDLINE">31544857</identifier>
  <identifier type="ISI">000428503500004</identifier><identifier type="urn">urn:nbn:de:0070-pub-29174941</identifier><identifier type="doi">10.3390/antib7010004</identifier>
<part><detail type="volume"><number>7</number></detail><detail type="issue"><number>1</number></detail>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<apa>Müller, K., &amp;amp; Falck, G. (2018). Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. &lt;em&gt;Antibodies&lt;/em&gt;, &lt;em&gt;7&lt;/em&gt;(1), 4. doi:10.3390/antib7010004</apa>
<ieee> K. Müller and G. Falck, “Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics”, &lt;em&gt;Antibodies&lt;/em&gt;,  vol. 7, 2018, : 4.</ieee>
<ama>Müller K, Falck G. Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. &lt;em&gt;Antibodies&lt;/em&gt;. 2018;7(1): 4.</ama>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Müller, K. &amp;amp; Falck, G. (2018). Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. &lt;em&gt;Antibodies&lt;/em&gt;, &lt;em&gt;7&lt;/em&gt;(1): 4. MDPI AG. doi:10.3390/antib7010004.&lt;/div&gt;</dgps>
<frontiers>Müller, K., and Falck, G. (2018). Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. &lt;em&gt;Antibodies&lt;/em&gt; 7:4.</frontiers>
<harvard1>Müller, K., &amp;amp; Falck, G., 2018. Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. &lt;em&gt;Antibodies&lt;/em&gt;, 7(1): 4.</harvard1>
<bio1>Müller K, Falck G (2018) &lt;br /&gt;Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics.&lt;br /&gt;Antibodies 7(1): 4.</bio1>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Müller, K., &amp;amp; Falck, G. (2018). Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. &lt;em&gt;Antibodies&lt;/em&gt;, &lt;em&gt;7&lt;/em&gt;(1), 4. doi:10.3390/antib7010004&lt;/div&gt;</apa_indent>
<angewandte-chemie>K.  Müller, and G.  Falck, “Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics”, &lt;em&gt;Antibodies&lt;/em&gt;, &lt;strong&gt;2018&lt;/strong&gt;, &lt;em&gt;7&lt;/em&gt;, : 4.</angewandte-chemie>
<wels>Müller, K.; Falck, G. (2018): Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics &lt;em&gt;Antibodies&lt;/em&gt;,7:(1):4</wels>
<mla>Müller, Kristian, and Falck, Georg. “Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics”. &lt;em&gt;Antibodies&lt;/em&gt; 7.1 (2018): 4.</mla>
<default>Müller K, Falck G (2018) &lt;br /&gt;&lt;em&gt;Antibodies&lt;/em&gt; 7(1): 4.</default>
<lncs> Müller, K., Falck, G.: Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics. Antibodies. 7, : 4 (2018).</lncs>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Müller, Kristian, and Falck, Georg. 2018. “Enzyme-Based labeling strategies for antibody–drug conjugates and antibody mimetics”. &lt;em&gt;Antibodies&lt;/em&gt; 7 (1): 4.&lt;/div&gt;</chicago>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2917494</recordIdentifier><recordCreationDate encoding="w3cdtf">2018-02-14T12:18:21Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2020-01-06T12:36:21Z</recordChangeDate>
</recordInfo>
</mods>